---
---

# 42 U.S.C., USLM ref /us/usc/t42/s300dd–21

* Portions Copyright © 2016 the authors of the https://github.com/publicdocs project.
  Use of this file is subject to the NOTICE at [https://github.com/publicdocs/uscode/blob/master/NOTICE](https://github.com/publicdocs/uscode/blob/master/NOTICE)
* See the [Document Metadata](././../../../../../..//README.md) for more information.
  This file is generated from historical government data; content and/or formatting may be inaccurate and out-of-date and should not be used for official purposes.

----------
----------

[Previous](./../../../../../..//us/usc/t42/ch6A/schXXII/ptB/m__us_usc_t42_ch6A_schXXII_ptB.md) | [Next](./../../../../../..//us/usc/t42/ch6A/schXXII/ptC/m__us_usc_t42_ch6A_schXXII_ptC.md) | [Root of Title](./../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fs300dd%E2%80%9321)

## § 300dd–21. Demonstration projects

    (a) __Definitions__ 

    As used in this section:

        (1) The term “individuals infected with the etiologic agent for acquired immune deficiency syndrome” means individuals who have a disease, or are recovering from a disease, attributable to the infection of such individuals with such etiologic agent, and as a result of the effects of such disease, are in need of subacute-care services.

        (2) The term “subacute care” means medical and health care services that are required for individuals recovering from acute care episodes that are less intensive than the level of care provided in acute-care hospitals, and includes skilled nursing care, hospice care, and other types of health services provided in other long-term-care facilities.

    (b) __Authorization to conduct three projects__ 

        The Secretary shall conduct three demonstration projects to determine the effectiveness and cost of providing the subacute-care services described in subsection (b) of this section to individuals infected with the etiologic agent for acquired immune deficiency syndrome, and the impact of such services on the health status of such individuals.

    (c) __Services__ 

        (1)

         The services provided under each demonstration project shall be designed to meet the specific needs of individuals infected with the etiologic agent for acquired immune deficiency syndrome, and shall include—

            (A)

             the care and treatment of such individuals by providing—

                (i) subacute care;

                (ii) emergency medical care and specialized diagnostic and therapeutic services as needed and where appropriate, either directly or through affiliation with a hospital that has experience in treating individuals with acquired immune deficiency syndrome; and

                (iii) case management services to ensure, through existing services and programs whenever possible, appropriate discharge planning for such individuals; and

            (B) technical assistance, to other facilities in the region served by such facility, that is directed toward education and training of physicians, nurses, and other health-care professionals in the subacute care and treatment of individuals infected with the etiologic agent for acquired immune deficiency syndrome.

        (2)

         Services provided under each demonstration project may also include—

            (A) hospice services;

            (B) outpatient care; and

            (C) outreach activities in the surrounding community to hospitals and other health-care facilities that serve individuals infected with the etiologic agent for acquired immune deficiency syndrome.

    (d) __Time and place__ 

    The demonstration projects shall be conducted—

        (1) during a 4-year period beginning not later than 9 months after November 4, 1988; and

        (2)

         at sites that—

            (A) are geographically diverse and located in areas that are appropriate for the provision of the required and authorized services; and

            (B) have the highest incidence of cases of acquired immune deficiency syndrome and the greatest need for subacute-care services.

    (e) __Evaluation and report__ 

    The Secretary shall evaluate the operations of the demonstration projects and shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Labor and Human Resources of the Senate—

        (1)

         not later than 18 months after the beginning of the first project, a preliminary report that contains—

            (A) a description of the sites at which the projects are being conducted and of the services being provided in each project; and

            (B) a preliminary evaluation of the experience of the projects in the first 12 months of operation; and

        (2)

         not later than 6 months after the completion of the last project, a final report that contains—

            (A) an assessment of the costs of subacute care for individuals infected with the etiologic agent for acquired immune deficiency syndrome, including a breakdown of all other sources of funding for the care provided to cover subacute care; and

            (B) recommendations for appropriate legislative changes.

    (f) __Other research__ 

    Each demonstration project shall provide for other research to be carried out at the site of such demonstration project including—

        (1) clinical research on acquired immune deficiency syndrome, concentrating on research on the neurological manifestations resulting from infection with the etiologic agent for such syndrome; and

        (2) the study of the psychological and mental health issues related to such syndrome.

    (g) __Authorization of appropriations__ 

        (1) To carry out this section, there are authorized to be appropriated $10,000,000 for fiscal year 1989 and such sums as are necessary for each of the fiscal years 1990 through 1992.

        (2) Amounts appropriated pursuant to paragraph (1) shall remain available until September 10, 1992.

    (h) __Services to veterans__ 

        The Secretary shall enter into an agreement with the Secretary of the Department of Veterans Affairs to ensure that appropriate provision will be made for the furnishing, through demonstration projects, of services to eligible veterans, under contract with the Department of Veterans Affairs pursuant to [section 1720 of title 38][/us/usc/t38/s1720].

([July 1, 1944, ch. 373][/us/act/1944-07-01/ch373], title XXIV, § 2421, as added [Pub. L. 100–607, title II][/us/pl/100/607/tII], § 211, Nov. 4, 1988, [102 Stat. 3088][/us/stat/102/3088]; amended [Pub. L. 100–527][/us/pl/100/527], § 10(1), (2), Oct. 25, 1988, [102 Stat. 2640][/us/stat/102/2640], 2641; [Pub. L. 100–690, title II][/us/pl/100/690/tII], § 2618(h), Nov. 18, 1988, [102 Stat. 4241][/us/stat/102/4241]; [Pub. L. 102–83][/us/pl/102/83], § 5(c)(2), Aug. 6, 1991, [105 Stat. 406][/us/stat/105/406].)

 __Amendments__ 

    1991—Subsec. (h). [Pub. L. 102–83][/us/pl/102/83] substituted “[section 1720 of title 38][/us/usc/t38/s1720]” for “[section 620 of title 38][/us/usc/t38/s620]”.

    1988—Subsec. (a)(1). [Pub. L. 100–690][/us/pl/100/690], § 2618(h)(1), substituted “ ‘individuals infected with the etiologic agent for acquired immune deficiency syndrome’ means individuals who” for “ ‘patients infected with the human immunodeficiency virus’ means persons who” and “such individuals with such etiologic agent” for “such person with the human immunodeficiency virus”.

    Subsec. (a)(2). [Pub. L. 100–690][/us/pl/100/690], § 2618(h)(2), substituted “individuals” for “persons”.

    Subsec. (b). [Pub. L. 100–690][/us/pl/100/690], § 2618(h)(3), substituted “individuals infected with the etiologic agent for acquired immune deficiency syndrome” for “patients infected with the human immunodeficiency virus” and “such individuals” for “such patients”.

    Subsec. (c)(1). [Pub. L. 100–690][/us/pl/100/690], § 2618(h)(4)(A), in introductory provisions substituted “individuals infected with the etiologic agent for acquired immune deficiency syndrome” for “patients infected with the human immunodeficiency virus”.

    Subsec. (c)(1)(A). [Pub. L. 100–690][/us/pl/100/690], § 2618(h)(4)(B), substituted in introductory provisions “such individuals” for “such patients”, in cl. (ii) “individuals with acquired immune deficiency syndrome” for “AIDS patients”, and in cl. (iii) “such individuals” for “patients”.

    Subsec. (c)(1)(B), (2)(C). [Pub. L. 100–690][/us/pl/100/690], § 2618(h)(4)(C), (5), substituted “individuals infected with the etiologic agent for acquired immune deficiency syndrome” for “patients infected with the human immunodeficiency virus”.

    Subsec. (d)(2)(B). [Pub. L. 100–690][/us/pl/100/690], § 2618(h)(6), substituted “cases of acquired immune deficiency syndrome” for “AIDS cases”.

    Subsec. (e)(2)(A). [Pub. L. 100–690][/us/pl/100/690], § 2618(h)(7), substituted “individuals infected with the etiologic agent for acquired immune deficiency syndrome” for “patients infected with the human immunodeficiency virus”.

    Subsec. (f)(1). [Pub. L. 100–690][/us/pl/100/690], § 2618(h)(8), substituted “acquired immune deficiency syndrome” for “the acquired immunodeficiency syndrome” and “etiologic agent for such syndrome” for “human immunodeficiency virus”.

    Subsec. (f)(2). [Pub. L. 100–690][/us/pl/100/690], § 2618(h)(9), substituted “such syndrome” for “the acquired immunodeficiency syndrome”.

    Subsec. (g)(1). [Pub. L. 100–690][/us/pl/100/690], § 2618(h)(10), substituted “fiscal year 1989” for “fiscal year 1988” and “fiscal years 1990 through 1992” for “fiscal years 1989 through 1991”.

    Subsec. (h). [Pub. L. 100–527][/us/pl/100/527] substituted “Secretary of the Department of Veterans Affairs” and “Department of Veterans Affairs” for “Administrator of the Veterans’ Administration” and “Veterans’ Administration”, respectively.

 __Change of Name__ 

    Committee on Labor and Human Resources of Senate changed to Committee on Health, Education, Labor, and Pensions of Senate by Senate Resolution No. 20, One Hundred Sixth Congress, Jan. 19, 1999.

    Committee on Energy and Commerce of House of Representatives treated as referring to Committee on Commerce of House of Representatives by [section 1(a) of Pub. L. 104–14][/us/pl/104/14/s1/a], set out as a note preceding [section 21 of Title 2][/us/usc/t2/s21], The Congress. Committee on Commerce of House of Representatives changed to Committee on Energy and Commerce of House of Representatives, and jurisdiction over matters relating to securities and exchanges and insurance generally transferred to Committee on Financial Services of House of Representatives by House Resolution No. 5, One Hundred Seventh Congress, Jan. 3, 2001.

 __Effective Date of 1988 Amendments__ 

    Amendment by [Pub. L. 100–690][/us/pl/100/690] effective immediately after enactment of [Pub. L. 100–607][/us/pl/100/607], which was approved Nov. 4, 1988, see [section 2600 of Pub. L. 100–690][/us/pl/100/690/s2600], set out as a note under [section 242m of this title][/us/usc/t42/s242m].

    Amendment by [Pub. L. 100–527][/us/pl/100/527] effective Mar. 15, 1989, see [section 18(a) of Pub. L. 100–527][/us/pl/100/527/s18/a], set out as a Department of Veterans Affairs Act note under [section 301 of Title 38][/us/usc/t38/s301], Veterans’ Benefits.

----------

[Previous](./../../../../../..//us/usc/t42/ch6A/schXXII/ptB/m__us_usc_t42_ch6A_schXXII_ptB.md) | [Next](./../../../../../..//us/usc/t42/ch6A/schXXII/ptC/m__us_usc_t42_ch6A_schXXII_ptC.md) | [Root of Title](./../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fs300dd%E2%80%9321)

----------
----------

[/us/usc/t38/s1720]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft38%2Fs1720
[/us/act/1944-07-01/ch373]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fact%2F1944-07-01%2Fch373
[/us/pl/100/607/tII]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F607%2FtII
[/us/stat/102/3088]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F102%2F3088
[/us/pl/100/527]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F527
[/us/stat/102/2640]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F102%2F2640
[/us/pl/100/690/tII]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690%2FtII
[/us/stat/102/4241]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F102%2F4241
[/us/pl/102/83]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F102%2F83
[/us/stat/105/406]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F105%2F406
[/us/pl/102/83]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F102%2F83
[/us/usc/t38/s1720]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft38%2Fs1720
[/us/usc/t38/s620]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft38%2Fs620
[/us/pl/100/690]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690
[/us/pl/100/690]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690
[/us/pl/100/690]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690
[/us/pl/100/690]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690
[/us/pl/100/690]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690
[/us/pl/100/690]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690
[/us/pl/100/690]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690
[/us/pl/100/690]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690
[/us/pl/100/690]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690
[/us/pl/100/690]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690
[/us/pl/100/690]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690
[/us/pl/100/527]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F527
[/us/pl/104/14/s1/a]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F104%2F14%2Fs1%2Fa
[/us/usc/t2/s21]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft2%2Fs21
[/us/pl/100/690]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690
[/us/pl/100/607]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F607
[/us/pl/100/690/s2600]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F690%2Fs2600
[/us/usc/t42/s242m]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fs242m
[/us/pl/100/527]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F527
[/us/pl/100/527/s18/a]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F100%2F527%2Fs18%2Fa
[/us/usc/t38/s301]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft38%2Fs301


